Xbiome Overview
- Year Founded
-
2017

- Status
-
Private
- Latest Deal Type
-
Series B2
- Investors
-
9
Xbiome General Information
Description
Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- Room 907, 9th Floor, Scientific Research Building
- Tsinghua Information Port, Nanshan District
- Shenzhen, Guangdong
- China
+86 0755 0000 0000
Xbiome Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Early Stage VC (Series B2) | 22-Dec-2021 | 000.00 | Completed | Generating Revenue | ||
4. Early Stage VC (Series B1) | 27-Nov-2020 | 000.00 | Completed | Generating Revenue | ||
3. Early Stage VC (Series B) | 04-Nov-2019 | 000.00 | 000.00 | Completed | Generating Revenue | |
2. Early Stage VC (Series A1) | 01-Jan-2019 | Completed | Generating Revenue | |||
1. Early Stage VC (Series A) | 01-Aug-2018 | Completed | Generating Revenue |
Xbiome Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. The company uses artifici
Biotechnology
Shenzhen, China
000.00
00000000000
000.00
Xbiome Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
00000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
00000000 00000000 | Venture Capital-Backed | Hong Kong, Hong Kong | 000 | 00000 | 00000000 | 00000 |
000000 000000 | Venture Capital-Backed | Brisbane, CA | 00 | 000.00 | 00000000000 | 000.00 |
Xbiome Patents
Xbiome Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220073996-A1 | Model for predicting treatment responsiveness based on intestinal microbial information | Pending | 22-Jan-2019 | 000000000 |
Xbiome Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Yan Tan Ph.D | Co-Founder & Chief Executive Officer |
Xbiome Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Hike Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Tiantu Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Primavera Capital Group | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Sky9 Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
YiMei Capital Management | Fund of Funds | Minority | 000 0000 | 000000 0 |
Xbiome Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Assembly Biosciences (M201 Program) | 25-Apr-2022 | 000000000 | Buildings and Property | 000 000 0 |